ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) J…

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

~Estimated

~$10 – $6,250

Nationwide Children's HospitalNCT05233397

Phase 2

Phase 2 Study of the MEK Inhibitor MEKTOVI® (Binimetinib) for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

MEKTOVI (binimetinib) is an oral, highly selective reversible inhibitor of mitogen-activated extracellular signal regulated kinase 1 (MEK1) and MEK2. The biolo…

Adamantinous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

~Estimated

~$10 – $6,250

Nationwide Children's HospitalNCT05286788